SCHEMBL5951867

SCHEMBL5951867

COP(Cc1ccccc1)c1cccc2c1CC(C)C2=O

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ACHE P22303 7/20 0.51
CSNK2A2 P19784 3/20 0.35
CSNK2A1 P68400 3/20 0.35
CYP19A1 P11511 2/20 0.34
CSNK2B P67870 2/20 0.33
ABCG2 Q9UNQ0 2/20 0.33
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
USP2 O75604 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
DUSP3 P51452 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
UTS2R Q9UKP6 1/20 0.32
HCRTR1 O43613 1/20 0.32
HCRTR2 O43614 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5952185 0.82 ACHE (0.43) ACHECSNK2A2CSNK2A1
SCHEMBL5952454 0.74 ACHE (0.55) ACHECSNK2A2CSNK2A1TDP1
SCHEMBL5951882 0.72 ACHE (0.69) ACHECYP19A1KDM4EMEN1MAPT
SCHEMBL5952905 0.72 ACHE (0.59) ACHECYP19A1HCRTR1HCRTR2
SCHEMBL3066323 0.69 ACHE (0.64) ACHEHCRTR1HCRTR2
SCHEMBL15746282 0.69 ACHE (1.00) ACHECYP19A1KDM4EMEN1MAPT
SCHEMBL5952073 0.69 ACHE (0.51) ACHECSNK2A2CSNK2A1CYP19A1
SCHEMBL5952092 0.67 ACHE (0.82) ACHECYP19A1KDM4EMAPT
SCHEMBL5953174 0.67 ACHE (0.67) ACHECSNK2A2CSNK2A1CYP19A1KDM4E
SCHEMBL5952018 0.67 ACHE (0.61) ACHECYP19A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7038070-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2006-05-02 US disclosed
US-6963017-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2005-11-08 US disclosed
EP-0968158-B1 METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM BASELL POLYOLEFINE GMBH (DE) 2005-08-10 EP disclosed
US-20050033076-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2005-02-10 US disclosed
US-20030009046-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2003-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050033076-A1 Preparation of preparing substituted indanones CYP1A2, CYP2J2, IDH3A ACHE 839/4885CSNK2A2 217/4885CSNK2A1 224/4885
US-20030009046-A1 Preparation of preparing substituted indanones CYP1A2, CYP1B1, CYP1A1 ACHE 820/4885CSNK2A2 260/4885CSNK2A1 236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.